A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Trial Details

  • 240 patients will be taking part in this study
  • Condition: Ulcerative Colitis
  • Intervention: Drug: Mirikizumab Drug: Placebo
  • Clinic: Delta Research Partners 608 Grammont Street, Monroe, Louisiana, United States


The main purpose of this study is to test the hypothesis that treatment with mirikizumab is superior to placebo in providing clinical benefit to participants with moderate to severe ulcerative colitis (UC). This study will also investigate how the body processes the drug.


Raj bhandari headshot for dt trial listings

Full Trial Details